Ganetespib is active in NSCLC and set to enter phase IIb/III trial in combination with docetaxel March 4, 2011
Germline SNPs inked to outcome of docetaxel-treated metastatic castration-resistant prostate cancer March 2, 2011
Drug-activated dendritic cell vaccine BPX-101 leads to antigen-specific immunity in mCRPC March 1, 2011
RSS